Receptors
-
{
- All
- News
-
The Rise Of Unapproved GLP-1 Products And A Growing Patient Safety Concern
GLP-1 receptor agonists have transformed diabetes and obesity treatment, but high demand fuels a risky market for unapproved and counterfeit products.
-
Struggling With Asthma? New Study Says This Common Diabetes Drug May Reduce Severe Attacks By 40 Per Cent
The study has found that people with asthma who were prescribed semaglutide appeared to have nearly 40 per cent fewer asthma attacks compared to similar people taking another type of diabetes medicine.
-
NDTV Lifeline X Diabetes: Doctor Shares The Key Checks Before Prescribing Weight-Loss Injections
Weight-loss injections like GLP-1 agonists aid diabetes and obesity but require thorough patient assessment before prescription.
-
NDTV Lifeline x Diabetes: Doctor Explains The Benefits And Side-Effects Of Weight-Loss Injections For Non-Obese Diabetics
Dr Anoop Misra explains the benefits and side effects that weight loss injections pose for non-obese diabetics. Here is what you need to know about the mechanisms behind weight loss injections.
-
Why Are Indians Quitting Weight-Loss Drugs Despite Lower Prices?
Generic GLP-1 drugs are cheaper than ever, but many Indians aren't staying on treatment. Here's why doctors say retention, not affordability, is the real challenge.
-
New Diabetes Drug Targets Metabolism, Avoids Ozempic Side Effects
Early studies suggest that it can lower blood sugar levels and increase fat burning while preserving muscle mass and normal appetite. This makes it a good option for people who struggle with the nausea, appetite loss, and muscle reduction.
-
Struggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle
A new study reveals that your genes could be the hidden hurdle, explaining the differences in how bodies respond to weight loss drugs.
-
Struggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle
A new study reveals that your genes could be the hidden hurdle, explaining the differences in how bodies respond to weight loss drugs.
-
Weight-Loss Surgery May Protect Your Heart More Than Drugs Like Ozempic, Mounjaro: Study
A new study suggests bariatric surgery may offer stronger long-term heart protection than GLP-1 drugs like Ozempic and Mounjaro.
-
Weight-Loss Surgery May Protect Your Heart More Than Drugs Like Ozempic, Mounjaro: Study
A new study suggests bariatric surgery may offer stronger long-term heart protection than GLP-1 drugs like Ozempic and Mounjaro.
-
Just Taking Ozempic Won't Help With Weight Loss, Daily Exercise Still Matters: New Study Warns
A new randomized trial shows that GLP-1 weight-loss drugs like liraglutide help reduce weight but don't improve physical fitness on their own. Structured exercise is essential for meaningful improvements in cardiorespiratory fitness, mobility, and lo
-
Just Taking Ozempic Won't Help With Weight Loss, Daily Exercise Still Matters: New Study Warns
A new randomized trial shows that GLP-1 weight-loss drugs like liraglutide help reduce weight but don't improve physical fitness on their own. Structured exercise is essential for meaningful improvements in cardiorespiratory fitness, mobility, and lo
-
Can Diabetes And Obesity Drugs Help Treat Psychiatric Disorders?
A recent study highlights a surprising potential benefit of diabetes and obesity drugs, GLP-1 receptor agonists, in improving overall health and possibly extending survival in people with serious psychiatric disorders.
-
Can Diabetes And Obesity Drugs Help Treat Psychiatric Disorders?
A recent study highlights a surprising potential benefit of diabetes and obesity drugs, GLP-1 receptor agonists, in improving overall health and possibly extending survival in people with serious psychiatric disorders.
-
Some Diabetes Patients Achieve Remission With GLP-1 Drugs: Italian Study
An Italian study shows that using GLP-1 receptor agonists can lead to remission in up to 18% of cases, especially when used early and in patients with fewer complications.
-
The Rise Of Unapproved GLP-1 Products And A Growing Patient Safety Concern
GLP-1 receptor agonists have transformed diabetes and obesity treatment, but high demand fuels a risky market for unapproved and counterfeit products.
-
Struggling With Asthma? New Study Says This Common Diabetes Drug May Reduce Severe Attacks By 40 Per Cent
The study has found that people with asthma who were prescribed semaglutide appeared to have nearly 40 per cent fewer asthma attacks compared to similar people taking another type of diabetes medicine.
-
NDTV Lifeline X Diabetes: Doctor Shares The Key Checks Before Prescribing Weight-Loss Injections
Weight-loss injections like GLP-1 agonists aid diabetes and obesity but require thorough patient assessment before prescription.
-
NDTV Lifeline x Diabetes: Doctor Explains The Benefits And Side-Effects Of Weight-Loss Injections For Non-Obese Diabetics
Dr Anoop Misra explains the benefits and side effects that weight loss injections pose for non-obese diabetics. Here is what you need to know about the mechanisms behind weight loss injections.
-
Why Are Indians Quitting Weight-Loss Drugs Despite Lower Prices?
Generic GLP-1 drugs are cheaper than ever, but many Indians aren't staying on treatment. Here's why doctors say retention, not affordability, is the real challenge.
-
New Diabetes Drug Targets Metabolism, Avoids Ozempic Side Effects
Early studies suggest that it can lower blood sugar levels and increase fat burning while preserving muscle mass and normal appetite. This makes it a good option for people who struggle with the nausea, appetite loss, and muscle reduction.
-
Struggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle
A new study reveals that your genes could be the hidden hurdle, explaining the differences in how bodies respond to weight loss drugs.
-
Struggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle
A new study reveals that your genes could be the hidden hurdle, explaining the differences in how bodies respond to weight loss drugs.
-
Weight-Loss Surgery May Protect Your Heart More Than Drugs Like Ozempic, Mounjaro: Study
A new study suggests bariatric surgery may offer stronger long-term heart protection than GLP-1 drugs like Ozempic and Mounjaro.
-
Weight-Loss Surgery May Protect Your Heart More Than Drugs Like Ozempic, Mounjaro: Study
A new study suggests bariatric surgery may offer stronger long-term heart protection than GLP-1 drugs like Ozempic and Mounjaro.
-
Just Taking Ozempic Won't Help With Weight Loss, Daily Exercise Still Matters: New Study Warns
A new randomized trial shows that GLP-1 weight-loss drugs like liraglutide help reduce weight but don't improve physical fitness on their own. Structured exercise is essential for meaningful improvements in cardiorespiratory fitness, mobility, and lo
-
Just Taking Ozempic Won't Help With Weight Loss, Daily Exercise Still Matters: New Study Warns
A new randomized trial shows that GLP-1 weight-loss drugs like liraglutide help reduce weight but don't improve physical fitness on their own. Structured exercise is essential for meaningful improvements in cardiorespiratory fitness, mobility, and lo
-
Can Diabetes And Obesity Drugs Help Treat Psychiatric Disorders?
A recent study highlights a surprising potential benefit of diabetes and obesity drugs, GLP-1 receptor agonists, in improving overall health and possibly extending survival in people with serious psychiatric disorders.
-
Can Diabetes And Obesity Drugs Help Treat Psychiatric Disorders?
A recent study highlights a surprising potential benefit of diabetes and obesity drugs, GLP-1 receptor agonists, in improving overall health and possibly extending survival in people with serious psychiatric disorders.
-
Some Diabetes Patients Achieve Remission With GLP-1 Drugs: Italian Study
An Italian study shows that using GLP-1 receptor agonists can lead to remission in up to 18% of cases, especially when used early and in patients with fewer complications.
